
The not-yet peer reviewed study by Pfizer and scientists from the University of Texas Medical Branch indicated the vaccine was effective in neutralizing virus with the so-called N501Y mutation of the spike protein.
from Healthcare/Biotech-Industry-Economic Times https://ift.tt/35nqxjh
via
IFTTT
0 comments:
Post a Comment